285 related articles for article (PubMed ID: 24931004)
21. Pituitary tumor-transforming gene-1 serves as an independent prognostic biomarker for gastric cancer.
Xu MD; Dong L; Qi P; Weng WW; Shen XH; Ni SJ; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
Gastric Cancer; 2016 Jan; 19(1):107-15. PubMed ID: 25627474
[TBL] [Abstract][Full Text] [Related]
22. NDRG4 hypermethylation is a potential biomarker for diagnosis and prognosis of gastric cancer in Chinese population.
Chen X; Yang Y; Liu J; Li B; Xu Y; Li C; Xu Q; Liu G; Chen Y; Ying J; Duan S
Oncotarget; 2017 Jan; 8(5):8105-8119. PubMed ID: 28042954
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-19b inhibits proliferation of gastric cancer cells by targeting B-cell CLL/lymphoma 3.
Wang H; Xiong M; Hu Y; Sun Y; Ma Q
Oncol Rep; 2016 Oct; 36(4):2079-86. PubMed ID: 27572553
[TBL] [Abstract][Full Text] [Related]
24. LETM1 is a potential biomarker that predicts poor prognosis in gastric adenocarcinoma.
Li H; Piao L; Xu D; Xuan Y
Exp Mol Pathol; 2020 Feb; 112():104333. PubMed ID: 31705880
[TBL] [Abstract][Full Text] [Related]
25. LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes
Byun HJ; Yoon JH; Lee SK
Yonsei Med J; 2020 Nov; 61(11):923-934. PubMed ID: 33107235
[TBL] [Abstract][Full Text] [Related]
26. Decreased expression of MEG3 contributes to retinoblastoma progression and affects retinoblastoma cell growth by regulating the activity of Wnt/β-catenin pathway.
Gao Y; Lu X
Tumour Biol; 2016 Feb; 37(2):1461-9. PubMed ID: 26662307
[TBL] [Abstract][Full Text] [Related]
27. MAL promoter hypermethylation as a novel prognostic marker in gastric cancer.
Buffart TE; Overmeer RM; Steenbergen RD; Tijssen M; van Grieken NC; Snijders PJ; Grabsch HI; van de Velde CJ; Carvalho B; Meijer GA
Br J Cancer; 2008 Dec; 99(11):1802-7. PubMed ID: 19002170
[TBL] [Abstract][Full Text] [Related]
28. Odd-skipped related 1 inhibits lung cancer proliferation and invasion by reducing Wnt signaling through the suppression of SOX9 and β-catenin.
Wang Y; Lei L; Zheng YW; Zhang L; Li ZH; Shen HY; Jiang GY; Zhang XP; Wang EH; Xu HT
Cancer Sci; 2018 Jun; 109(6):1799-1810. PubMed ID: 29660200
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic inactivation of T-box transcription factor 5, a novel tumor suppressor gene, is associated with colon cancer.
Yu J; Ma X; Cheung KF; Li X; Tian L; Wang S; Wu CW; Wu WK; He M; Wang M; Ng SS; Sung JJ
Oncogene; 2010 Dec; 29(49):6464-74. PubMed ID: 20802524
[TBL] [Abstract][Full Text] [Related]
30. Methylation of ASC/TMS1 promoter is associated with poor prognosis of patients with gastric cancer.
Wu L; Zhang C; Wang X; Ding X; Deng J; Liang H
Clin Transl Oncol; 2016 Mar; 18(3):296-303. PubMed ID: 26260914
[TBL] [Abstract][Full Text] [Related]
31. The Pleckstrin and Sec7 domain-containing gene as a novel epigenetic modification marker in human gastric cancer and its clinical significance.
Zhu X; Liu J; Xu X; Zhang C; Dai D
Int J Oncol; 2015 Jan; 46(1):195-204. PubMed ID: 25355626
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of the long non-coding RNA FENDRR is associated with poor prognosis in gastric cancer and FENDRR regulates gastric cancer cell metastasis by affecting fibronectin1 expression.
Xu TP; Huang MD; Xia R; Liu XX; Sun M; Yin L; Chen WM; Han L; Zhang EB; Kong R; De W; Shu YQ
J Hematol Oncol; 2014 Aug; 7():63. PubMed ID: 25167886
[TBL] [Abstract][Full Text] [Related]
33. Odd-skipped related 1 plays a tumor suppressor role in ovarian cancer via promoting follistatin-like protein 1 transcription.
Yu Z; Ouyang L
Hum Cell; 2022 Nov; 35(6):1824-1837. PubMed ID: 35964260
[TBL] [Abstract][Full Text] [Related]
34. TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.
Liu WB; Han F; Jiang X; Chen HQ; Zhao H; Liu Y; Li YH; Huang C; Cao J; Liu JY
Oncotarget; 2015 Aug; 6(25):21225-39. PubMed ID: 26056045
[TBL] [Abstract][Full Text] [Related]
35. Reduction of TIP30 correlates with poor prognosis of gastric cancer patients and its restoration drastically inhibits tumor growth and metastasis.
Li X; Zhang Y; Cao S; Chen X; Lu Y; Jin H; Sun S; Chen B; Liu J; Ding J; Wu K; Fan D
Int J Cancer; 2009 Feb; 124(3):713-21. PubMed ID: 18972434
[TBL] [Abstract][Full Text] [Related]
36. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
[TBL] [Abstract][Full Text] [Related]
37. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
[TBL] [Abstract][Full Text] [Related]
38. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
39. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
40. Methylation of protocadherin 10, a novel tumor suppressor, is associated with poor prognosis in patients with gastric cancer.
Yu J; Cheng YY; Tao Q; Cheung KF; Lam CN; Geng H; Tian LW; Wong YP; Tong JH; Ying JM; Jin H; To KF; Chan FK; Sung JJ
Gastroenterology; 2009 Feb; 136(2):640-51.e1. PubMed ID: 19084528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]